CD19 neutralization likely affects BCR signaling, but blocking CD19 alone in mice with pre-established experimental HP, even though causing a 30% decrease in lung B cell numbers (not shown), did not alleviate inflammation resulting from an antigenic recall. This evidence concerns the gene CD19 and hypersensitivity pneumonitis.